ClinicalTrials.gg
Sign In
CompletedNCT04772716POCUpdated Feb 26, 2021

Surgical Outcome at HFSUH

An observational study in Surgical Outcome, sponsored by Haramaya Unversity. Completed at 1 site in Ethiopia. Per ClinicalTrials.gov, last updated 2021-02-26.

Sponsored by Haramaya Unversity · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
352
Sex
All
01

Study summary

the study was conducted on already intervened hospital patients with surgical management and their final outcome was followed from the chart of the patients.

Read the detailed description

It was a prospective chart review of operated patient at Hiwot fana specialized hospital for different emergency as well elective surgeries. The study subjects signed informed written consent and their data collected anonymously. the follow up protocol was until discharge from hospital the longest date as 30 days.

02

Conditions studied

  • Surgical Outcome

Keywords

  • outcome
03

In context

Lead sponsor

Haramaya Unversity is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

all patient admitted surgical ward and underwent surgical intervention

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all operated patients at surgical ward

Exclusion criteria

Exclusion Criteria:

  • patients operated at other facilities and transferred here. readmission within a month of discharge
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
352 participants (actual)
Target follow-up
7 Days
Patient registry
Yes

Interventions

  • Procedureoperation

    The intervention was not decided by the investigator but studied following emergency or elective surgeries undergoing in the system

06

What researchers measure

Primary outcomes

  1. post operative complications

    the outcome variable is adichotomous on with no complication and has complictions

    Time frame: 7 days

07

Study locations

1 site
  • HFSUH
    Harar, Harari NS 251, Ethiopia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2019 to primary completion in Jan 2020, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2021
First posted
Feb 26, 2021
StartActual
Aug 1, 2019
Primary completionActual
Jan 31, 2020
CompletionActual
Feb 28, 2020
Last update
Feb 26, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 26, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04772716
Lead sponsor
Haramaya Unversity
Responsible party
Badhaasaa (Dr, Haramaya Unversity) — Principal investigator
First posted
Feb 26, 2021
Start date
Aug 1, 2019
Primary completion
Jan 31, 2020
Completion
Feb 28, 2020
Last update
Feb 26, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Haramaya Unversity

Start the discussion